Various HMG-CoA reductase inhibitors

被引：0

作者：

Thiery, J ^{[1
]}

Seidel, D ^{[1
]}

机构：

[1] Univ Munich, Klinikum Grosshadern, Inst Klin Chem, D-81377 Munich, Germany

来源：

INTERNIST | 1999年 / 40卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：113 / 114

页数：2

共 50 条

[41] HMG-CoA reductase inhibitors in atherosclerosis.
Buckley, BM
INSULIN RESISTANCE, METABOLIC DISEASES AND DIABETIC COMPLICATIONS, 1999, 1177 : 219 - 224
[42] BIOCHEMISTRY AND PHARMACOLOGY OF HMG-COA REDUCTASE INHIBITORS
ENDO, A
ATHEROSCLEROSIS VIII, 1989, 817 : 775 - 780
[43] Pleiotropic effects of HMG-CoA reductase inhibitors
Werner, N
Nickenig, G
Laufs, U
BASIC RESEARCH IN CARDIOLOGY, 2002, 97 (02) : 105 - 116
[44] HMG-COA REDUCTASE INHIBITORS, GEMFIBROZIL, AND MYOPATHY
TOBERT, JA
AMERICAN JOURNAL OF CARDIOLOGY, 1995, 75 (12): : 862 - 862
[45] Pleiotropic effects of the HMG-CoA reductase inhibitors
Mihos, Christos G.
Santana, Orlando
INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2011, 4 : 261 - 271
[46] Comparative Tolerability of the HMG-CoA Reductase Inhibitors
John A. Farmer
Guillermo Torre-Amione
Drug Safety, 2000, 23 : 197 - 213
[47] HMG-COA REDUCTASE INHIBITORS AND SLEEP - REPLY
VGONTZAS, AN
KALES, A
BIXLER, EO
MANFREDI, RL
TYSON, KL
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 52 (01) : 110 - 111
[48] More on comparison of HMG-CoA reductase inhibitors
Hsu, I
Spinler, SA
ANNALS OF PHARMACOTHERAPY, 1996, 30 (04) : 414 - 415
[49] HMG-CoA reductase inhibitors and the risk of fractures
Meier, CR
Schlienger, RG
Kraenzlin, ME
Schlegel, B
Jick, H
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (24): : 3205 - 3210
[50] THE DISCOVERY AND DEVELOPMENT OF HMG-COA REDUCTASE INHIBITORS
ENDO, A
JOURNAL OF LIPID RESEARCH, 1992, 33 (11) : 1569 - 1582